Company / SG&A per Share
Maze Therapeutics, Inc. SG&A per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$14.08
FY2025
5-year range
$14.08 / $14.08
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#10 of 210
Health Care
What the data says
Among 210 Health Care companies, Maze Therapeutics, Inc. is in the bottom 5% for sg&a per share.
Based on SEC 10-K filings.
14.08 in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 210This company $14.08 Sector average $40.75
▼
-65.5% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.08 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026